Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report
- Written by PR Newswire Asia - News Pronto RSS
 |
Highlights:
- Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation
- Strengthening profile at investment, scientific and clinical conferences
- Dr David Stamler appointed Chief Executive Officer
- Cash balance as at 31 March 2021 of A$32.8M
MELBOURNE, Australia, April 29, 2021 /PRNewswire/ -- Alterity Therapeutics...
Read more: Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report